LeonaBio (LONA) Current Assets (2019 - 2026)

LeonaBio (LONA) has 8 years of Current Assets data on file, last reported at $69.2 million in Q1 2026.

• Current Assets for Q1 2026 came in at $69.2 million, up 73.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.2 million (up 73.64% YoY), and the FY2025 annual result was $89.5 million, up 63.12% from the prior year.
• Current Assets fell to $69.2 million in Q1 2026 per LONA's latest filing, from $89.5 million in the prior quarter.
• Over five years, Current Assets peaked at $269.2 million in Q1 2022 and troughed at $27.0 million in Q3 2025.
• A 5-year average of $135.9 million and a median of $128.6 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2025 and 2026: Current Assets slumped 69.81% in 2025, then jumped 73.64% in 2026.
• A 5-year view of Current Assets shows it stood at $207.5 million in 2022, then dropped by 25.44% to $154.7 million in 2023, then sank by 64.56% to $54.8 million in 2024, then surged by 63.12% to $89.5 million in 2025, then declined by 22.64% to $69.2 million in 2026.
• Business Quant data shows LONA's Current Assets at $69.2 million in Q1 2026, $89.5 million in Q4 2025, and $27.0 million in Q3 2025.